Encompass Health Corporation found using ticker (EHC) have now 13 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 104 and 75 with a mean TP of 81.62. Now with the previous closing price of 66.95 this now indicates there is a potential upside of 21.9%. The 50 day MA is 68.82 and the 200 moving average now moves to 69.68. The company has a market cap of $6,779m. Visit the company website at: https://www.encompasshealth.com
The potential market cap would be $8,264m based on the market concensus.
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment’s hospice services comprise in-home services to terminally ill patients and their families. As of April 11, 2022, it operated 147 hospitals, 251 home health locations, and 96 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
